CAS:3522-50-7
Appearance:Brown to black particles or powder
Storage:RT.
Purity:>98%
![](http://solarbio.net/data/png/jgs/3522-50-7.png)
Suitable for in vitro ubiquitination
Quantity: 1 mg
MW: 9.7 kDa
Source: E. coliderived human Ubiquitin protein Contains an Nterminal HA (YPYDVPDYA) tag
Stock: Lyophilized from a solution in deionized water.
Solubility: Reconstitute at 10 mg/mL in an aqueous solution.
Purity: > 95% by SDS‐PAGE
Use: Recombinant Human HA-Ubiquitin can be conjugated to substrate proteins via the subsequent actions of a
Ubiquitin activating (E1) enzyme, a Ubiquitin conjugating (E2) enzyme, and a Ubiquitin ligase (E3). Reaction
conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human HAUbiquitin
concentration of 5-50 uM.
Storage: Use a manual defrost freezer and avoid repeated freeze thaw cycles.
24 months from date of receipt, -20 to -70 ℃ as supplied.
6 months, -20 to -70 ℃ under sterile conditions after reconstitution.
Note:Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
![](http://solarbio.net/themes/ec36_01/slo/imgs/zhuyi.png)